Rising biotech investments and demand for therapeutic proteins are fueling rapid growth in protein expression systems, with mammalian cell platforms and essential reagents driving innovation. The ...

The cost-effective, easy-to-use T7 expression system has been integral to Escherichia coli protein production since its introduction in 1986. Now, a just-developed enhancement is making it even better ...

Bacillus subtilis has emerged as a pre‐eminent model organism for the study and application of protein expression and secretion, owing to its robust secretory pathways and genetic tractability. Its ...

Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have found that a key ...

In the evolving fields of genomics and protein expression, staying updated with the latest advancements is essential. This eBook offers a handpicked collection of posters at the ELRIG Drug Discovery ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T persistence and function. Additionally, there is a growing trend towards ...

The most successful players — both old and new — are those focusing on operational risk control rather than assay novelty.

Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and production.

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS). The study, ...